Apr 21 2023

Discovery Life Sciences Acquires ReachBio Research Labs

"We share Discovery's passion for science and believe that combining our expertise in cell-based assays and drug screening with Discovery's broad multi-omics capabilities will enable us to provide a.…

Read more →
Apr 25 2022

AAI Annual Meeting, Immunology2022 | Portland, OR May 6-10

The ReachBio team is delighted to be returning to the Annual Meeting for The American Association of Immunologists next month in Portland, Oregon. Our CSO, Dr. Emer Clarke, will be presenting a.…

Read more →
Mar 20 2020

World ADC London

March 2-5 2020 | London, UK

Read more →
Aug 27 2019

ReachBio Featured on Sickle Cell Anemia News

An article referencing ReachBio's newdrug screening platform to discover therapeutic compounds that trigger the production of fetal hemoglobin (HbF) to treat sickle cell disease (SCD) and other.…

Read more →
Aug 13 2019

A Platform for Screening Drugs to Treat Sickle Cell Disease

SEATTLE, August 13, 2019 -- ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering a drug screening platform to assess.…

Read more →
Jun 20 2016

Human PBMCs Available Online

ReachBio Research Labs now makes it easy for you to purchase Human Peripheral Blood Mononuclear Cells (PBMCs) online! The blood that is used to make our primary cell products is obtained from healthy.…

Read more →
Mar 04 2016

Society of Toxicology 55th Annual Meeting and ToxExpo

The Society of Toxicology 55th Annual Meeting and ToxExpo is next week! ReachBio will be exhibiting at the ToxExpo from March 14th through the 16th. We welcome all to stop by our booth #1300 to talk.…

Read more →
Dec 31 2015

Happy New Year from ReachBio Research Labs!

It has been a good year for growth at ReachBio Research Labs! We have really appreciated working with our existing clients who have come back, time after time with new contract services. We have.…

Read more →